The federal government has put Andrx's new drug applications on hold after raising issues with its manufacturing operations following a federal inspection last May. The generic drug maker said in a release that the agency may sanction the company, which could include product recalls or the suspension of production. Andrx said it had filed a plan to correct the problems found during the inspection. Trading of Andrx's stock was halted before the announcement.
- read this AP story for more